tci Medicare Compliance & Reimbursement - 2020 Issue Q3
ICD-10 Coding: Differentiate Substance Abuse With New Diagnosis Code Options
Subscribe or sign in to view the full article.
Article Overview
This article summarizes a set of ICD-10-CM update highlights tied to the 2021 code set and related CMS/CDC guidance. It is aimed at coders, billers, and clinical documentation teams who need to understand broad areas of diagnosis code change, including substance-related disorders, esophagitis, influenza-related respiratory conditions, headache coding, and vaping-related reporting guidance. The discussion also notes where the updates came from and why they matter for timely policy and documentation review.
Why This Topic Matters
The article helps readers identify which parts of the updated diagnosis code set and related guidance may affect current coding workflows, documentation review, and compliance planning before the effective date.
Article Sections
-
Register Updates to the F10-F19 Range
Covers updates to the substance-related diagnosis code family and related code additions discussed in the 2021 ICD-10-CM release. It also notes the broader context of withdrawal-related coding and poisoning-related updates.
-
Know These Changes on Esophagitis-Related Codes
Summarizes selected esophagitis and gastro-esophageal reflux coding changes associated with the annual ICD-10-CM update. The section references stakeholder input and the broader move toward more specific diagnosis reporting.
-
Add Influenza Coding Changes to Your List
Reviews changes affecting acute upper respiratory infection coding when influenza is involved. It addresses instructions that were moved within the code family and the impact on several respiratory diagnosis categories.
-
Get Ready for Headache Code Expansion
Describes the reorganization of the headache diagnosis category in the updated code set. The section focuses on the new structure of the family and the need to distinguish unspecified headache reporting.
-
Feds Revisit U07.0 Guidelines
Covers CDC-related guidance on vaping-related disorder and related documentation considerations. It also references the broader approach to reporting signs, symptoms, and manifestations in vaping-related cases.
What You Will Learn
- Which broad diagnosis families were highlighted in the 2021 ICD-10-CM update
- How selected substance-related, respiratory, headache, and vaping-related topics were grouped in the article
- What types of guidance changes were discussed by CMS and CDC
- Which kinds of documentation and reporting areas may need review before the effective date
Who Should Read This
- Medical coders
- Coding managers
- Physician practices
- Clinical documentation staff
- Billing and reimbursement professionals
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com